CargarIdioma (ES)Atenciรณn al cliente
EmpresarialesMรณvilRedes socialesMarketingTecnologรญaArte y fotografรญaEmpleoDiseรฑoEducaciรณnPresentaciones y charlas pรบblicasGobierno y org. sin รกnimo de lucroAtenciรณn sanitariaInternetDerechoLiderazgo y gestiรณnMotorIngenierรญaSoftwareReclutamiento y RR.ย HH.Venta al por menorVentasServiciosCienciasPYMES y liderazgoAlimentaciรณnMedio ambienteEconomรญa y finanzasDatos y anรกlisisRelaciones con inversoresDeportesMeditaciรณnNoticias y polรญticaViajesDesarrollo personalSector inmobiliarioEntretenimiento y humorSalud y medicinaDispositivos y hardwareEstilo de vida

Cambiar idioma

Idioma
๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*, profile picture

๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*

124 Slideshow
Sort by
Pharmaceutical Liquid Dosage Form (Pharmaceutics).pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Complexation and Protein Binding: Unit IV (ii) [BP302T] .pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Complexation and Protein Binding: Unit IV (i) [BP302T].pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Surface and Interfacial Phenomena: Unit III Physical Pharmaceutics-I [BP302T].pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
General Consideration and Production of Enzymes (P'ceutical Biotech 6th Sem.).pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
PELLETS - BASIC AND COMPOSITION UNIT DOSAGE FORM [Industrial Pharmacy-I].pdf
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Preparation and Evaluation of Vanishing Cream.pdf
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Tablet Coating, Types, Coating Materials, & Coating Pans [Industrial Pharmacy-Ist Theory]
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Preparation and Evaluation of Cold Cream: Experiment Findings.pdf
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Niosome Formulation And Evaluations .pdf
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Niosome An Non-Ionic Surfactant Vesicles.pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
๐Ž๐ซ๐š๐ฅ ๐๐š๐ฉ๐ž๐ซ ๐๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง: ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐‚๐จ๐ง๐Ÿ๐ž๐ซ๐ž๐ง๐œ๐ž (๐ˆ๐‘๐“๐„๐‚ ๐Ÿ.๐ŸŽ-๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’); The Current Advanced Drug Delivery System: Non-ionic Surfactant Vesicles as Potential Vesicular Delivery Carriers For Tuberculosis (TB)
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Pharmaceutical Suspension.ppt
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
por๐Œ๐ซ. ๐‘๐š๐ก๐ฎ๐ฅ ๐๐š๐ฅ*
ย